NERVGEN PHARMA CORP. Cash Flows From Used In Investing Activities
NERVGEN PHARMA CORP. (NGEN) reported Cash Flows From Used In Investing Activities of CAD 100.93 thousand for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Cash Flow
ifrs-full:CashFlowsFromUsedInInvestingActivities · last filed 2026-03-31
| Period end | Cash Flows From Used In Investing Activities 12 month |
|---|---|
| 2025-12-31 | 100.93K CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 58.87K CAD 40-F · filed 2026-03-31 |